Pharmacy-based bone mass measurement to assess osteoporosis risk.

MLA

Elliott, Mary E., et al. “Pharmacy-Based Bone Mass Measurement to Assess Osteoporosis Risk.” The Annals of Pharmacotherapy, vol. 36, no. 4, Apr. 2002, pp. 571–77. EBSCOhost, https://doi.org/10.1345/aph.1A299.

APA

Elliott, M. E., Meek, P. D., Kanous, N. L., Schill, G. R., Weinswig, P. A., Bohlman, J. P., Zimpel, C. L., Jensen, B. C., Walters, D. R., Sutter, S. L., Peterson, A. N., Peterson, R. M., & Binkley, N. C. (2002). Pharmacy-based bone mass measurement to assess osteoporosis risk. The Annals of Pharmacotherapy, 36(4), 571–577. https://doi.org/10.1345/aph.1A299

Chicago

Elliott, Mary E, Patrick D Meek, Nathan L Kanous, Gary R Schill, Patricia A Weinswig, John P Bohlman, Casey L Zimpel, et al. 2002. “Pharmacy-Based Bone Mass Measurement to Assess Osteoporosis Risk.” The Annals of Pharmacotherapy 36 (4): 571–77. doi:10.1345/aph.1A299.